Podiatrist · Bronx, NY
NPI
1568402576
Since 2006
Specialty
Podiatrist
Code 213E00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
3201 Grand Concourse
Bronx, NY, 10468
Phone (718) 365-6363
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,799 services
Medicare patients, 2024
291
Average age 74
Drug cost, 2024
$2.5M
7,928 prescriptions
Company payments, 2025
$939
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Debello was code J1010 (injection, methylprednisolone acetate, 1 mg), 800 times for 16 patients. In total John A Debello billed 1,799 services in 49 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 800 | 16 | $0.10 | $82.35 |
| 11721 Nail Procedure | Office | 220 | 131 | $38.61 | $8,494 |
| 11056 Removal or Shaving of Skin Growth | Office | 159 | 104 | $71.94 | $11K |
| 99213 Office E&M - Established | Office | 135 | 104 | $74.99 | $10K |
| 99212 Office E&M - Established | Office | 66 | 51 | $47.54 | $3,138 |
| 73630 X-ray - Lower Extremity | Office | 46 | 36 | $29.50 | $1,357 |
| 11721 Nail Procedure | Facility | 31 | 30 | $20.59 | $638 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 28 | 21 | $0.77 | $21.58 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 27 | 21 | $0.09 | $2.56 |
| 99203 Office E&M - New | Office | 25 | 25 | $100.81 | $2,520 |
| 99307 SNF E&M | Facility | 16 | 14 | $36.00 | $576 |
| 99304 SNF E&M | Facility | 16 | 16 | $70.81 | $1,133 |
| 20550 Musculoskeletal | Office | 16 | 13 | $50.49 | $808 |
By year: 2022 $81K for 1,353 services; 2023 $100K for 1,694 services; 2024 $70K for 1,799 services.
Medicare prescription drug claims, 2024
In 2024, the drug John A Debello prescribed most often to Medicare patients was Ciclopirox (Ciclopirox Olamine), with 1,245 prescriptions and refills. In total John A Debello wrote 7,928 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciclopirox Ciclopirox Olamine | 1,245 | 1,409 | 430 | $66K |
| Ammonium Lactate Generic | 1,020 | 1,117 | 383 | $23K |
| Clobetasol Propionate Generic | 736 | 1,058 | 188 | $390K |
| Diclofenac Sodium Generic | 540 | 602 | 228 | $189K |
| Doxepin Hcl Generic | 463 | 508 | 198 | $345K |
| Clotrimazole Generic | 403 | 415 | 147 | $14K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 354 | 361 | 132 | $97K |
| Ciclopirox Generic | 303 | 308 | 135 | $8,279 |
| Jublia Efinaconazole | 224 | 248 | 43 | $193K |
| Meloxicam Generic | 183 | 183 | 133 | $296 |
| Ketoconazole Generic | 178 | 188 | 74 | $14K |
| Betamethasone Dipropionate Generic | 160 | 189 | 54 | $19K |
| Chlorpromazine Hcl Generic | 141 | 141 | 46 | $112K |
| Terbinafine Hcl Generic | 131 | 146 | 70 | $777 |
| Budesonide Er Budesonide | 121 | 121 | 38 | $92K |
Brand drugs: - claims; generic drugs: 7,001 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John A Debello $939 ($939 in general payments such as food, travel and fees) from 5 companies. The largest payer was Arthrex, Inc. with $288.
| Company | Payments | Amount |
|---|---|---|
| Arthrex, Inc. | 3 | $288 |
| Gotham Surgical Solutions & Devices, Inc. | 6 | $286 |
| Paratek Pharmaceuticals, Inc. | 21 | $171 |
| Averitas Pharma Inc. | 6 | $136 |
| Treace Medical Concepts, Inc. TMCI | 2 | $57.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.